✨ Your Portfolio is fetched and updated from zerodha.
Micro Pharmaceuticals

Gujarat Terce Laboratories Ltd.

GUJTERC

Market Cap
₹45 Cr.
P/E
15.32

Gujarat Terce Laboratories Ltd.

  • Guj. Terce Lab
  • Deccan Health Care
  • Chandra Bhagat Pharm
FAQs on Gujarat Terce Laboratories Ltd. Shareprice

Guj. Terce Lab has given better returns compared to its competitors.
Guj. Terce Lab has grown at ~-10.01% over the last 1yrs while peers have grown at a median rate of -22.14%

Guj. Terce Lab is not expensive.
Latest PE of Guj. Terce Lab is 15.54, while 3 year average PE is 19.33.
Also latest EV/EBITDA of Guj. Terce Lab is 12.81 while 3yr average is 50.43.

View FAQ's On Business
Growth Table
  • Gujarat Terce Laboratories Ltd.
  • Deccan Health Care
  • Chandra Bhagat Pharm
Balance Sheet
  • Gujarat Terce Laboratories Ltd.
  • Deccan Health Care
  • Chandra Bhagat Pharm
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Gujarat Terce Laboratories Ltd.
  • Deccan Health Care
  • Chandra Bhagat Pharm
Cash Flow
  • Gujarat Terce Laboratories Ltd.
  • Deccan Health Care
  • Chandra Bhagat Pharm
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Gujarat Terce Laboratories Ltd.
  • Deccan Health Care
  • Chandra Bhagat Pharm
Quarterly Results
  • Gujarat Terce Laboratories Ltd.
  • Deccan Health Care
  • Chandra Bhagat Pharm
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Rhapson method.
Learn how to use Reverse DCF
FAQs on Gujarat Terce Laboratories Ltd. Financials

Balance sheet of Guj. Terce Lab is strong.
But short term working capital might become an issue for this company.

The debt of Guj. Terce Lab is decreasing.
Latest debt of Guj. Terce Lab is ₹3.11 Crs as of Sep-24.
This is less than Mar-24 when it was ₹3.78 Crs.

Yes, profit is increasing.
The profit of Guj. Terce Lab is ₹2.96 Crs for TTM, ₹0.24 Crs for Mar 2024 and -₹1.67 Crs for Mar 2023.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Guj. Terce Lab latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are majorly tied in miscellaneous assets

View FAQ's On Shareholding
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech